Clinical update from a Phase 1, First-in-Human, Open-label Single Agent Study of SUPLEXA Therapeutic Cells in Patients with Metastatic Solid Tumours and Haematologic Malignancies

SUPLEXA cell therapy - Alloplex Biotherap

https://jitc.bmj.com/content/10/Suppl_2/A662

Rohit Joshi 1; Jeffrey Goh 2; Warren Joubert 2; Vineet Kwarta 3; Meena Okera 3; Sarwan Bishnoi 3; Jim Lederer 4; Frank Borriello 4; Sharron Gargosky 4

Oct 6, 2022